PT  - JOURNAL ARTICLE
AU  - Canavan, Neil
TI  - Gliptin Wars
DP  - 2008 Nov 01
TA  - MD Conference Express
PG  - 24--26
VI  - 8
IP  - 7
4099  - http://mdc.sagepub.com/content/8/7/24.short
4100  - http://mdc.sagepub.com/content/8/7/24.full
AB  - Following closely behind vildagliptin and sitagliptin, the two currently marketed compounds in the DPP-IV inhibitor drug class, are the pipeline agents saxagliptin and alogliptin. This article discusses data concerning all four molecules.